Northwestern Mutual Wealth Management CO Biotechnology

Northwestern Mutual Wealth Management CO

$121 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
ORMP Oramed Pharmaceuticals Inc.	$82.3M	$3,000 0.0% of portfolio	1,575	Q3 2022 New
TVTX Travere Therapeutics, Inc.	$1.02B	$3,000 0.0% of portfolio	204	Q4 2024 New
ARWR Arrowhead Pharmaceuticals, Inc.	$1.56B	$2,000 0.0% of portfolio	234	Q1 2025 Reduced 88.21%
CGTX Cognition Therapeutics Inc	$16.1M	$2,000 0.0% of portfolio	6,567	Q1 2025 Added 11.93%
CYTK Cytokinetics Inc	$3.48B	$2,000 0.0% of portfolio	65	Q1 2025 Added 490.91%
NVAX Novavax Inc	$561M	$2,000 0.0% of portfolio	365	Q1 2025 Added 3.11%
PGEN Precigen, Inc.	$381M	$2,000 0.0% of portfolio	1,626	Q1 2025 New
RYTM Rhythm Pharmaceuticals, Inc.	$3.66B	$2,000 0.0% of portfolio	48	Q1 2025 New
ALLO Allogene Therapeutics, Inc.	$190M	$1,000 0.0% of portfolio	1,000	Q3 2021 New
ANIX Anixa Biosciences Inc	$105M	$1,000 0.0% of portfolio	500	Q1 2025 New
IMUX Immunic, Inc.	$30M	$1,000 0.0% of portfolio	1,500	Q1 2024 New
INAB In8 Bio, Inc.	$57.1M	$1,000 0.0% of portfolio	8,263	Q1 2025 New
GLUE Monte Rosa Therapeutics, Inc.	$272M	$1,000 0.0% of portfolio	300	Q3 2021 New
SAGE Sage Therapeutics, Inc.	$533M	$1,000 0.0% of portfolio	250	Q1 2025 New
RARE Ultragenyx Pharmaceutical Inc.	$1.85B	$1,000 0.0% of portfolio	53	Q1 2025 New
TSVT 2seventy Bio, Inc.	$189M	$0 0.0% of portfolio	58	Q4 2024 Reduced 78.99%
FDMT 4 D Molecular Therapeutics, Inc.	$137M	$0 0.0% of portfolio	1	Q4 2024 Reduced 98.51%
ATNM Actinium Pharmaceuticals, Inc.	$42.6M	$0 0.0% of portfolio	107	Q3 2020 New
AKBA Akebia Therapeutics, Inc.	$708M	$0 0.0% of portfolio	5	Q1 2025 New
ALT Altimmune, Inc.	$199M	$0 0.0% of portfolio	100	Q1 2019 New
RCUS Arcus Biosciences, Inc.	$668M	$0 0.0% of portfolio	1	Q3 2021 Reduced 99.96%
ARMP Armata Pharmaceuticals, Inc.	$86M	$0 0.0% of portfolio	571	Q2 2019 New
CRDF Cardiff Oncology, Inc.	$169M	$0 0.0% of portfolio	48	Q1 2025 Reduced 55.56%
CDXS Codexis, Inc.	$186M	$0 0.0% of portfolio	1	Q2 2024 Reduced 83.33%
EDIT Editas Medicine, Inc.	$217M	$0 0.0% of portfolio	1	Q4 2024 Reduced 98.36%
IMMX Immix Biopharma, Inc.	$39.8M	$0 0.0% of portfolio	80	Q1 2025 New
LXRX Lexicon Pharmaceuticals, Inc.	$232M	$0 0.0% of portfolio	500	Q3 2019 Reduced 55.08%
LYRA Lyra Therapeutics, Inc.	$255M	$0 0.0% of portfolio	6,000	Q1 2025 New
MDGL Madrigal Pharmaceuticals, Inc.	$5.66B	$0 0.0% of portfolio	3	Q1 2025 Reduced 25.0%
MNOV Medicinova Inc	$61.8M	$0 0.0% of portfolio	305	Q1 2021 New
NERV Minerva Neurosciences, Inc.	$10.4M	$0 0.0% of portfolio	100	Q3 2022 New
CDXC Chroma Dex Corp.	$420M	$0 0.0% of portfolio	42	Q1 2025 New
PDSB Pds Biotechnology Corp	$32.7M	$0 0.0% of portfolio	257	Q1 2025 New
PYXS Pyxis Oncology, Inc.	$40M	$0 0.0% of portfolio	12	Q4 2024 New
SANA Sana Biotechnology, Inc.	$845M	$0 0.0% of portfolio	200	Q4 2024 Reduced 18.03%
SMMT Summit Therapeutics Inc.	$5.3B	$0 0.0% of portfolio	47	Q1 2025 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.